The coronavirus outbreak has touched virtually every aspect of our lives, including our court system. On March 18, a New Jersey state court declared it was delaying proceedings in a case against American International Industries, the parent company for talc-product manufacturer Clubman.
In the lawsuit, two hairdressers, Margaret Lashley and Dwayne Johnson, seek justice for their exposure to asbestos in Clubman brand’s cosmetic talc products they used in a barbershop. The plaintiffs claim that this exposure caused their fatal cancer.
Floridian women in the West Palm Beach area, please take note: The Breast Institute in West Palm Beach is unauthorized to perform mammography.
The U.S. Food and Drug Administration (FDA) took corrective action against The Breast Institute, located in West Palm Beach, Florida, after declaring that the mammograms performed by the facility are a “serious risk to human health.”
Bayer opened a Pandora’s box when it acquired Monsanto Co. in 2018. Since acquiring the maker of Roundup weed killer, the multinational pharmaceutical giant has faced lawsuits from nearly 49,000 Roundup users who claim the product causes non-Hodgkin’s lymphoma (NHL).
The small Connecticut-based lab that first sounded the alarm about NDMA contamination in ranitidine (Zantac) is now issuing a similar warning over metformin, a commonly-prescribed, first-line treatment for type-2 diabetes.
A group of women is accusing breast implant manufacturer Allergan of intentionally keeping the public in the dark about the cancer risk their product poses. Six women filed lawsuits against the company for its understated label warnings regarding BIOCELL textured implants, and the plaintiffs explain other ways in which the company’s cloak-and-dagger reporting tactics put the women in harm’s way.
As news coverage of e-cigarette related illnesses has faded into the background, the U.S. House of Representatives took a major step last week by passing the Reversing the Youth Tobacco Epidemic Act, which bans all sales of flavored vape as well as tobacco products, namely menthol cigarettes.
Bayer CEO Werner Baumann's $63 billion gamble on purchasing Monsanto continues to spiral downward. Not only is Bayer facing more than 43,000 glyphosate claims from Roundup users afflicted with cancer, but now, a small army of farmers are lining up to sue the company over dicamba, another Monsanto herbicide that has been destroying food crops.
Twenty-one sex trafficking survivors who filed lawsuits against various hotels where they were victimized will not have their cases consolidated before a single court, the Judicial Panel on Multidistrict Litigation ruled last week.
Despite the fact that all of the cases share the same cause of action – namely, that the hotels failed to train their staff members on how to recognize and report suspected sex trafficking activity – the JPML ruled that the cases were too diverse to be consolidated.
A jury in Johnson & Johnson's home state of New Jersey ordered the health care and cosmetic products giant to pay punitive damages of $750 million in a talc mesothelioma case last week. The verdict comes on top of $37 million in compensatory damages awarded to four plaintiffs who claimed their disease was caused by asbestos-contaminated talc.
Proton pump inhibitors (PPIs) such as Prilosec (omeprazole) and Nexium (esomeprazole) have been linked to numerous serious side effects, ranging from pneumonia, osteoporosis and kidney stones to cardiovascular disease and cancer.
Three juries have determined that glyphosate, the active ingredient in the herbicide Roundup, is a carcinogen. These verdicts are in agreement with the International Agency for Research on Cancer, which concluded that glyphosate is likely to cause cancer, and other scientific studies that have linked glyphosate to the disease. However, recently published research focusing on Roundup's “inert” ingredients suggests that there may be more to it than glyphosate.
Drugmaker Mylan Pharmaceuticals, Inc. has issued a voluntary recall for three lots of the antacid Nizatidine (Axid) after traces of N-Nitrosodimethylamine (NDMA) were discovered in the active ingredient. Although no adverse events have been reported, Mylan is notifying all distributors, retailers, and customers, and has been making arrangements for the return of the affected products.
Last month, Drug Safety News featured a story about Valisure, a small, independent pharmaceutical testing lab in Connecticut that discovered carcinogenic NDMA in Zantac. It wasn't outside contamination – it was a problem with the molecule at the heart of the formulation.
Adding to the list of potential health hazards of “vaping,” a research team at Harvard University's T.H. Chan School of Public Health has discovered a biocontaminant in JUUL vape oil that can lead to serious, long-term respiratory damage.
Six Roundup cancer cases are scheduled to go to trial right after the New Year, even as Bayer is attempting to negotiate a global settlement in Berlin. Among those plaintiffs are two children who suffer from non-Hodgkin's lymphoma (NHL), allegedly due to exposure to glyphosate, the active ingredient in the herbicide.
After traces of carcinogenic industrial chemicals have been found in the common blood pressure medication valsartan, the antidepressant alprazolam (Xanax) and the antacid ranitidine (Zantac), regulators are turning their sights on metformin – an otherwise relatively innocuous and safe prescription drug used by type-2 diabetics to control
Last year's Camp Fire, which literally wiped out the town of Paradise, California and killed 85 people, was ultimately caused by an aging power line that PG&E had failed to maintain properly. Furthermore, that egregious example of gross negligence is just one indication of “systemic problems” and the ways in which this convicted corporate felon and recidivist has been ignoring safety regulations for years.
Prominent mediation attorney Kenneth Feinberg – best known as architect of the 9/11 Victims Compensation Fund – recently told the German news magazine WirtschaftsWoche (“Economic Week”) that mediation between Bayer AG and U.S. glyphosate plaintiffs is progressing – but don't look for a settlement or resolution anytime soon.